DE69825978D1 - Genabgabe-vehikel die das apoptosis vp2 inducierendes protein, und/oder apoptin exprimiert - Google Patents

Genabgabe-vehikel die das apoptosis vp2 inducierendes protein, und/oder apoptin exprimiert

Info

Publication number
DE69825978D1
DE69825978D1 DE69825978T DE69825978T DE69825978D1 DE 69825978 D1 DE69825978 D1 DE 69825978D1 DE 69825978 T DE69825978 T DE 69825978T DE 69825978 T DE69825978 T DE 69825978T DE 69825978 D1 DE69825978 D1 DE 69825978D1
Authority
DE
Germany
Prior art keywords
apoptosis
apoptin
relates
express
delivery vehicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69825978T
Other languages
English (en)
Other versions
DE69825978T2 (de
Inventor
Hubertus Noteborn
Maria Pietersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leadd BV
Original Assignee
Leadd BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97201121A external-priority patent/EP0872552A1/de
Application filed by Leadd BV filed Critical Leadd BV
Application granted granted Critical
Publication of DE69825978D1 publication Critical patent/DE69825978D1/de
Publication of DE69825978T2 publication Critical patent/DE69825978T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69825978T 1997-04-15 1998-04-15 Genabgabe-Vehikel die das Apoptosis VP2 induzierendes Protein, und/oder Apoptin Exprimiert Expired - Fee Related DE69825978T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP97201121 1997-04-15
EP97201121A EP0872552A1 (de) 1997-04-15 1997-04-15 Genabgabe-Vehikel die das Apoptosis VP2 induzierendes Protein und/oder Apoptin exprimiert
EP97203595 1997-11-18
EP97203595A EP0878546A1 (de) 1997-04-15 1997-11-18 Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
PCT/NL1998/000213 WO1998046760A1 (en) 1997-04-15 1998-04-15 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin

Publications (2)

Publication Number Publication Date
DE69825978D1 true DE69825978D1 (de) 2004-10-07
DE69825978T2 DE69825978T2 (de) 2005-09-15

Family

ID=26146368

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69825978T Expired - Fee Related DE69825978T2 (de) 1997-04-15 1998-04-15 Genabgabe-Vehikel die das Apoptosis VP2 induzierendes Protein, und/oder Apoptin Exprimiert

Country Status (17)

Country Link
EP (2) EP0878546A1 (de)
JP (1) JP2001521387A (de)
KR (1) KR100528755B1 (de)
AT (1) ATE275200T1 (de)
AU (1) AU750162B2 (de)
BR (1) BR9808542A (de)
CA (1) CA2286165C (de)
CZ (1) CZ299963B6 (de)
DE (1) DE69825978T2 (de)
DK (1) DK0975764T3 (de)
ES (1) ES2227822T3 (de)
NO (1) NO994967L (de)
NZ (1) NZ500012A (de)
PL (1) PL196607B1 (de)
PT (1) PT975764E (de)
SK (1) SK285724B6 (de)
WO (1) WO1998046760A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL196605B1 (pl) * 1997-08-12 2008-01-31 Leadd Bv Sposób oznaczania zdolności transformującej, sposób oznaczania predyspozycji do przekształcania się w komórkę nowotworową, sposób oznaczania predyspozycji do dziedziczenia rodzajów raka, sposób oznaczania mutacji genu i diagnostyczny zestaw testowy
EA200100770A1 (ru) * 1999-01-11 2002-02-28 Леадд Б.В. Применение агентов, индуцирующих апоптоз, в лечении (ауто)имунных заболеваний
AU2004233486B2 (en) * 1999-01-11 2007-09-13 Leadd B.V. Use of apoptosis inducing agents in the treatment of (auto)immune diseases
ATE347597T1 (de) 1999-09-02 2006-12-15 Leadd Bv Apoptin bindendes protein
EP1081226A1 (de) * 1999-09-02 2001-03-07 Leadd B.V. Apoptin-bindendes Protein
JP2003516152A (ja) * 1999-12-10 2003-05-13 レアト ベー．フェー． アポプチン会合タンパク質
AU2002246455A1 (en) * 2001-03-30 2002-10-15 Leadd B.V. Fusion proteins for specific treatment of cancer and auto-immune diseases
KR100561985B1 (ko) 2004-07-03 2006-03-22 고려대학교 산학협력단 종양 특이적 아폽틴 발현 카세트 및 이를 포함하는아데노바이러스 발현 벡터
KR100877824B1 (ko) 2005-11-11 2009-01-12 한국생명공학연구원 Ｅ2ｅｐｆ ｕｃｐ-ｖｈｌ 상호작용 및 그 용도
CN109111527B (zh) * 2018-08-03 2022-03-15 沈阳金石生物制药有限公司 靶向特异性诱导肿瘤细胞凋亡的gip34-vp3融合蛋白及其制备方法和应用
CN109266714A (zh) * 2018-10-12 2019-01-25 广州医科大学 一种循环肿瘤细胞的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
NL9301272A (nl) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel

Also Published As

Publication number Publication date
NZ500012A (en) 2001-04-27
KR100528755B1 (ko) 2005-11-15
CA2286165C (en) 2009-02-03
JP2001521387A (ja) 2001-11-06
EP0975764A1 (de) 2000-02-02
PL196607B1 (pl) 2008-01-31
PL336312A1 (en) 2000-06-19
CZ299963B6 (cs) 2009-01-07
KR20010006460A (ko) 2001-01-26
ES2227822T3 (es) 2005-04-01
NO994967L (no) 1999-12-15
EP0878546A1 (de) 1998-11-18
AU6856398A (en) 1998-11-11
ATE275200T1 (de) 2004-09-15
CA2286165A1 (en) 1998-10-22
BR9808542A (pt) 2000-05-23
DK0975764T3 (da) 2005-01-03
AU750162B2 (en) 2002-07-11
SK285724B6 (sk) 2007-07-06
WO1998046760A1 (en) 1998-10-22
SK142899A3 (en) 2000-06-12
DE69825978T2 (de) 2005-09-15
CZ349399A3 (cs) 2000-02-16
PT975764E (pt) 2004-11-30
NO994967D0 (no) 1999-10-12
EP0975764B1 (de) 2004-09-01

Similar Documents

Publication Publication Date Title
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
DE69825978D1 (de) Genabgabe-vehikel die das apoptosis vp2 inducierendes protein, und/oder apoptin exprimiert
FI852626L (fi) Menetelmä ihmisen tuumorinekroositekijän valmistamiseksi ja sitä koodaava DNA
CY1117786T1 (el) Διαφορικα εκφραζομενα σε ογκους γονιδιακα προϊοντα και χρηση αυτων
PT797676E (pt) Vector adenoviral recombinante e metodos de utilizacao
BR9908823A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
BR0009505A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
HUP0003911A2 (hu) Neoplazmák kezelése vírusokkal
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
ATE207958T1 (de) Äusserliche domäne von c-erbb-2:gp75
ES2061708T3 (es) Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus.
WO1998007850A3 (en) Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
ATE363489T1 (de) In tumoren vervielfältigte gensequenzen und deren diagnostische verwendungen
FI813539L (fi) Maenniskans hybridleukosyt-interferoner
DK0961831T3 (da) Humant alfa-endokin
ATE71632T1 (de) Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression.
ATE229977T1 (de) Peptide mit antiproliferativen eigenschaften
HUP9903921A2 (hu) Tumor nekrózis faktorral rokon ligandum
CA2167578A1 (en) Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
WO2002086071A3 (en) Cancer-testis antigens
DK1536006T3 (da) Cancerantigener og anvendelse deraf
WO1999028461A3 (en) Methods and means for inducing apoptosis by interfering with bip-like proteins
ATE76099T1 (de) Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia- viren, die sich in cho-zellen vermehren koennen.
DK1967586T3 (da) 84P2A9: prostata- og testikelspecifikt protein med høj ekspression ved prostatacancer
WO2000071564A8 (en) Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee